Newsletter
FemTech Focus

FemTech Focus

Femtech experts talk about the innovative technology, services, and products that are improving women's health and wellness.

Latest From Series

Nua Surgical improving cesareans with a novel retractable device- Ep 175

NUA Surgical is a multi-award-winning start-up dedicated to creating innovative surgical solutions in obstetrics and gynaecology. Headquartered in Galway, a global Medtech hub on the West Coast of Ireland, the company has developed the patented SteriCISIONTM C-Section Retractor, designed to improve ergonomics and make cesarean delivery safer by providing superior access and visualisation during surgery. The Founding team have over 50 years combined experience and are working with key opinion leaders around the world to answer the most pressing unmet clinical needs in women’s health. The company is currently raising investment to achieve the significant milestones of a First in Woman study and FDA Clearance.Barry McCann is the Founder and CEO of NUA Surgical, an award-winning start up innovating in women’s health. Barry first graduated with a business degree from the National University of Ireland, Galway in 2003 and spent the next decade in commercial and fundraising management roles, primarily in the not-for-profit and professional sports sectors. In 2017, he returned to his alma mater to complete a Masters degree in Medical Device Innovation, in parallel with a full-time Fellowship at BioInnovate Ireland (Stanford Biodesign Affiliate). It was during this time that he identified significant unmet clinical needs in obstetrics and gynecology, resulting in NUA Surgical emerging as a spin out company. He also holds diplomas in Anatomy, Project Management & Online Marketing. Barry lives in Galway, Ireland with his wife (an abstract artist) and their two children, Elsie and Teddy.https://www.linkedin.com/in/barrymccanngalway/ https://www.linkedin.com/company/nua-surgical/ https://twitter.com/NuaSurgical https://twitter.com/barry_mccann------FemTech Focus is a 501c3 non-profit organization founded to bring awareness externally and internally for the FemTech industry and to empower the key stakeholders including entrepreneurs, investors, physicians, governments, and biopharma with resources and research to elevate women’s health and wellness globally. Subscribe and Donate: www.femtechfocus.orgThe FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings women's health experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products that are improving women, female, and girl's health and wellness, collectively known as FemTech. The podcast gives the host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.Linkedin: @FemTech Focus @Brittany BarretoTwitter: @Femtech_Focus @DrBrittBInstagram: @FemTechFocus @DrBrittanyBarretoFacebook: @FemTech Focus @Dr. Brittany Barreto
August 8, 2022

Natural Cycles, FDA-approved birth control app based on body temperature – Ep 174

Natural Cycles° is a leading women’s health company that developed the world’s first birth control app, which has been used by millions of women around the world. As a Class II medical device, the NC° app is cleared by the FDA in the United States and certified to be used as a contraceptive in Europe, Australia, and Singapore. It has also received regulatory clearances to integrate with third party wearables. For a monthly or annual subscription fee, users have access to and can switch between NC° Birth Control, NC° Plan Pregnancy, and NC° Follow Pregnancy modes within the app. NC° Birth Control’s clinical effectiveness and real life effectiveness is proven to be 93% effective with typical use and 98% effective with perfect use. Founded in 2013 by Physicists Dr. Elina Berglund and Dr. Raoul Scherwitzl, Natural Cycles° is committed to pioneering women’s health with research and passion. The company’s on-staff research team has contributed to 14 peer-reviewed research papers.Dr. Elina Berglund Scherwitzl is the CEO and co-founder of Natural Cycles - the world’s first app to be certified as a contraception both in Europe and by the FDA. She was part of the team that discovered the Higgs boson at the CERN laboratory, which led to the Nobel Prize in physics in 2013. Following this success, Elina applied her skills from particle physics to create a unique algorithm that could accurately pinpoint when a woman was fertile based on her body temperature.https://www.naturalcycles.com/Instagram: https://www.instagram.com/naturalcyclesFacebook: https://www.facebook.com/NaturalCyclesNCTikTok: @naturalcycles FemTech Focus is a 501c3 non-profit organization founded to bring awareness externally and internally for the FemTech industry and to empower the key stakeholders including entrepreneurs, investors, physicians, governments, and biopharma with resources and research to elevate women’s health and wellness globally. Subscribe and Donate: www.femtechfocus.orgThe FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings women's health experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products that are improving women, female, and girl's health and wellness, collectively known as FemTech. The podcast gives the host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness. Linkedin: @FemTech Focus @Brittany BarretoTwitter: @Femtech_Focus @DrBrittBInstagram: @FemTechFocus @DrBrittanyBarretoFacebook: @FemTech Focus @Dr. Brittany Barreto
August 1, 2022

BD's newest HPV screening assay – Episode 173

Molly Broache serves as Associate Director, US Region, Medical Affairs for BD Integrated Diagnostic Solutions (IDS) and is also licensed as a women’s health nurse practitioner in both Maryland and Virginia. Molly manages a team of medical science liaisons responsible for specimen management, microbiology, and women’s health & cancer. Molly’s clinical areas of expertise include women’s healthcare, gynecology, infectious disease diagnostic tests, and women’s health screening guidelines. Molly is a member of the American College of Obstetricians and Gynecologists (ACOG), Nurse Practitioners in Women’s Health (NPWH), American Society for Colposcopy and Cervical Pathology (ASCCP), and the Medical Science Liaison Society (MSLS). She serves on the membership committee for ASCCP and the Cervical Cancer Screening Initiative – Provider Workgroup for the American Cancer Society. Molly holds two Bachelor’s degrees from Johns Hopkins University, in both molecular biology and nursing. She also holds a master’s degree in nursing from Georgetown University, where she received her training as a nurse practitioner. Molly is currently completing her Doctor of Nursing Practice degree at the University of Maryland, Baltimore.BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.LinkedIn: www.linkedin.com/company/bd1/ | Twitter @BDandCo | Instagram: @becton_dickinson
July 25, 2022

Prenatal genetic screening as a critical maternal health tool with Natera – Episode 171

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visitwww.natera.com. @NateraGenetics, @NateraWomen
July 18, 2022

Data Privacy of FemTech Apps in a post Roe v Wade America – Bonus

Laura is a Legal Officer at Privacy International, where leads the work on privacy and reproductive rights. Laura contributed to Privacy International’s 2020 report on data exploitation and reproductive rights, and currently supports research, advocacy and litigation efforts to hold Big Tech and governments accountable for unlawful interferences with privacy.Prior to joining PI, Laura was a Litigation Fellow at the Open Society Justice Initiative, where she supported claimant-side human rights litigation globally. Previously, Laura was a Visiting Professional at the Inter-American Court of Human [email protected] @privacyint
July 15, 2022

Verity Now wants car safety standards to include females – Episode 170

Beth A. Brooke, VERITY NOW Co-Chair Beth A. Brooke retired as the Global Vice-Chair – Public Policy at EY and a member of the firm’s Global Executive Board. Ms. Brooke had public policy responsibility for the firm’s operations in over 150 countries and was the global sponsor for EY’s Diversity and Inclusiveness efforts.During the Clinton Administration, she worked in the U.S. Department of the Treasury, where she was responsible for all tax policy matters related to insurance and managed care.  She played important roles in the healthcare reform and Superfund reform efforts.Ms. Brooke serves on the board of The New York Times Company, eHealth, Beta Bionics, Tricolor Holdings, and SHEEX.  She is also a member of the Board of the United States Olympic and Paralympic Committee, the Partnership for Global LGBTI Equality, The Conference Board, The Aspen Institute, and Out Leadership. She is a member of the inaugural class of the Henry Crown Fellows of The Aspen Institute, the Committee of 200, and the International Women’s Forum. Ms. Brooke is a prominent voice around the world on Diversity and Inclusion, including most prominently on LGBT inclusion and women. She has been named eleven times to the list of Forbes “World’s 100 Most Powerful Women“. In 2017, she received the Theodore Roosevelt Award, the top individual honor bestowed by the U.S. National Collegiate Athletic Association (NCAA).  She has also been inducted into the Indiana Basketball Hall of Fame.Company bioIn the United States, women are over 17 percent more likely to die and 73 percent more likely to be seriously injured in a vehicle crash than men. VERITY (Vehicle Equity Rules in Transportation) NOW unites people to fight for equality in vehicle safety by educating on, and advocating for, crash testing standards that protect men and women equally to make cars safer for all.Connect:Twitter: @BethBrooke_EYTwitter: @Veritynow_LinkedIn: Beth A. BrookeLinkedIn: VERITY NowFacebook: VERITY Now Coalition
July 11, 2022

Listen on your favorite player

New to Podcasts? It's easy to get started!

FemTech Focus

The FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings femtech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as femtech) that are improving women's health and wellness.

Though many leaders in femtech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
View All Episodes

Host

Brittany Barreto, PhD

Brittany Barreto, PhD

Dr. Brittany Barreto is the unconventional serial entrepreneur that proves that anything is possible with hard work and heart. While finishing her PhD in genetics at Baylor College of Medicine, Brittany became the CEO and Co-Founder of the revolutionary dating app Pheramor. The ambitious venture was the first nationwide DNA-based dating app to hit the market, reaching an eager audience that resulted in 50% growth, month over month. Brittany was also successful in fundraising $1.3 million for her startup, her founder’s journey took a pivot three years later when she embarked on a new path as the Senior Venture Associate at Capital Factory, a notable innovation player in Texas.

Under her leadership the Houston accelerator portfolio grew by an impressive 205%. It was also during this time that Brittany realized that Houston needed more former-founder mentors like herself to help usher in the next generation of Femtech startups. Dr. Brittany Barreto now has her sights on advancing the Femtech community through her latest world-changing venture - FemTech Focus.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Reducing Mental Health Stigma among Healthcare Professionals featuring Corey Feist Reducing mental health stigma and mental health and well-being among healthcare professionals.